New Applications for Traditional Drugs in Inflammatory Bowel Disease: What Do Cochrane Reviews Tell Us?

被引：4

作者：

Chande, Nilesh ^{[1
]}

Marshall, John K. ^{[2
]}

Seow, Cynthia H. ^{[3
,4
]}

Sandborn, William J. ^{[5
]}

Parker, Claire E. ^{[6
]}

Nelson, Sigrid ^{[6
]}

Feagan, Brian G. ^{[1
,6
,7
,8
]}

机构：

[1] Univ Western Ontario, Div Gastroenterol, Dept Med, London, ON N6A 5K8, Canada

[2] McMaster Univ, Div Gastroenterol, Hamilton, ON, Canada

[3] Univ Calgary, Div Gastroenterol, Dept Med, Calgary, AB T2N 1N4, Canada

[4] Univ Calgary, Dept Community Hlth Sci, Calgary, AB T2N 1N4, Canada

[5] Univ Calif San Diego, Div Gastroenterol, La Jolla, CA 92093 USA

[6] Univ Western Ontario, Robarts Clin Trials Inc, Robarts Res Inst, London, ON N6A 5K8, Canada

[7] Univ Western Ontario, Dept Med, London, ON N6A 5K8, Canada

[8] Univ Western Ontario, Dept Epidemiol & Stat, London, ON N6A 5K8, Canada

来源：

INFLAMMATORY BOWEL DISEASES | 2015年 / 21卷 / 12期

关键词：

inflammatory bowel disease; treatment; systematic review; meta-analysis; ACTIVE ULCERATIVE-COLITIS; RANDOMIZED CLINICAL-TRIAL; CROHNS-DISEASE; DOUBLE-BLIND; RHEUMATOID-ARTHRITIS; ORAL BUDESONIDE; METHOTREXATE MONOTHERAPY; MAINTENANCE THERAPY; COMBINATION THERAPY; RELEASE MESALAZINE;

D O I：

10.1097/MIB.0000000000000631

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Although multiple innovative treatments of inflammatory bowel disease have become available, research continues to refine the value of existing drug therapies for Crohn's disease and ulcerative colitis. What can Cochrane reviews tell us about evolving applications for traditional agents in inflammatory bowel disease? A Cochrane Collaboration symposium held at the 2014 Digestive Diseases Week annual meeting addressed this question. This article reviews the data presented at that session.

引用

页码：2948 / 2957

页数：10

共 104 条

[1] Risk of Melanoma and Non-Melanoma Skin Cancer in Ulcerative Colitis Patients Treated With Thiopurines: A Nationwide Retrospective Cohort [J].

Abbas, Ali M. ;

Almukhtar, Rawaa M. ;

Loftus, Edward V., Jr. ;

Lichtenstein, Gary R. ;

Khan, Nabeel .

AMERICAN JOURNAL OF GASTROENTEROLOGY, 2014, 109 (11) :1781-1793

[2] Current, new and future biological agents on the horizon for the treatment of inflammatory bowel diseases [J].

Amiot, Aurelien ;

Peyrin-Biroulet, Laurent .

THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2015, 8 (02) :66-82

[3] ORAL FLUTICASONE PROPIONATE IN ACTIVE DISTAL ULCERATIVE-COLITIS [J].

ANGUS, P ;

SNOOK, JA ;

REID, M ;

JEWELL, DP .

GUT, 1992, 33 (05) :711-714

[4]

[Anonymous], COCHRANE DATABASE SY

[5]

[Anonymous], COCHRANE DATABASE SY

[6] Comparison between methotrexate and azathioprine in the treatment of chronic active Crohn's disease: a randomised, investigator-blind study [J].

Ardizzone, S ;

Bollani, S ;

Manzionna, G ;

Imbesi, V ;

Colombo, E ;

Porro, GB .

DIGESTIVE AND LIVER DISEASE, 2003, 35 (09) :619-627

[7] Association Between Thiopurine Use and Nonmelanoma Skin Cancers in Patients With Inflammatory Bowel Disease: A Meta-Analysis [J].

Ariyaratnam, Jonathan ;

Subramanian, Venkataraman .

AMERICAN JOURNAL OF GASTROENTEROLOGY, 2014, 109 (02) :163-169

[8]

Arora S, 1999, HEPATO-GASTROENTEROL, V46, P1724

[9]

AZADKHAN AK, 1977, LANCET, V2, P892

[10] Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis [J].

Baecklund, E ;

Iliadou, A ;

Askling, J ;

Ekborn, A ;

Backlin, C ;

Granath, F ;

Catrina, AT ;

Rosenquist, R ;

Feltelius, N ;

Sundström, C ;

Klareskog, L .

ARTHRITIS AND RHEUMATISM, 2006, 54 (03) :692-701

← 1 2 3 4 5 6 7 8 9 10 →